Ofloxacin Price Trend

Ofloxacin Price Trend, Index and Forecast

Track the latest insights on ofloxacin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Ofloxacin Prices Outlook Q3 2026

• USA: USD 51,913/MT
• China: USD 43,142/MT
• Germany: USD 48,378/MT
• France: USD 49,441/MT
• Canada: USD 44,913/MT

Ofloxacin Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the third quarter of 2026, the ofloxacin prices in the USA reached 51,913 USD/MT in September. The instruction was incomplete: no replacement line was supplied, so the passage is returned unchanged rather than altered with invented figures. Prices moved upward as pharmaceutical formulators and distributors maintained steady procurement of the active ingredient through the quarter. Tighter availability of prompt batches encouraged suppliers to hold firmer offers, limiting the scope for discounting. Higher replacement costs for imported intermediate materials added further pressure to domestic quotations. Distributors kept inventories lean, which restricted the volume of material available to spot buyers. Consistent demand from generic and branded tablet and injectable manufacturers supported the firmer pricing environment through the period.

In September, during the third quarter of 2026, ofloxacin prices in China reached 43,142 USD/MT. Prices increased as domestic active ingredient producers maintained steady operating rates while facing firmer input and processing costs. Export oriented buyers kept procurement active, reducing the volume of material available for the local spot market. Formulators serving tablet and injectable manufacturing lines continued regular purchasing despite the firmer cost base. Freight and handling charges at major ports added to delivered values for regional buyers. Suppliers stayed disciplined on offers, reinforcing the upward tone through the quarter.

During the third quarter of 2026, the ofloxacin prices in Germany reached 48,378 USD/MT in September. Prices advanced as European pharmaceutical manufacturers maintained steady offtake of imported active ingredient despite firmer supplier offers. Tighter prompt availability across the regional market encouraged formulators to secure forward coverage rather than rely on spot purchases. Higher replacement costs linked to limited prompt supply added to the upward pressure on local quotations. Distributors maintained conservative inventory positions, which restricted the volume of material available to buyers seeking immediate delivery. Firm demand from tablet, injectable and ophthalmic formulation producers kept offtake steady through the period.

During the third quarter of 2026, the ofloxacin prices in France reached 49,441 USD/MT in September. Prices trended higher as regional formulators continued regular procurement despite firmer supplier offers across the quarter. Limited prompt availability of the active ingredient encouraged buyers to build modest forward positions to secure coverage. Higher logistics and handling costs for inbound shipments added further pressure to delivered values. Distributors kept inventories conservative, which limited the volume of material offered into the spot market. Steady demand from hospital and retail pharmacy channels supported consistent offtake despite the firmer pricing environment.

During the third quarter of 2026, the ofloxacin prices in Canada reached 44,913 USD/MT in September. Prices climbed as cross border availability tightened and replacement costs rose across the North American active ingredient supply chain. Canadian formulators faced firmer regional offers as strong demand from the USA absorbed available volumes and reduced export flexibility. Distributors serving tablet and injectable manufacturers maintained steady procurement despite the firmer pricing environment. Limited domestic production kept the market reliant on imported material, reinforcing the impact of overseas price movements on local offers. Suppliers held firm on offers given the restricted prompt availability through the period.

Ofloxacin Prices Outlook Q2 2026

• USA: USD 50,840/MT
• China: USD 41,800/MT
• Germany: USD 47,069/MT
• France: USD 48,010/MT
• Canada: USD 43,890/MT

During the second quarter of 2026, the ofloxacin prices in the USA reached 50,840 USD/MT in June. The market moved upward as supply availability remained relatively constrained across the generic pharmaceutical sector. Manufacturing disruptions and quality related limitations affecting sterile formulations contributed to tighter availability and encouraged buyers to secure material more proactively. Higher upstream costs for aromatic feedstocks and other chemical inputs also increased API manufacturing expenses.

During the second quarter of 2026, the ofloxacin prices in China reached 41,800 USD/MT in June. Prices increased as upstream chemical costs remained firm and continued to influence API manufacturing economics. Aromatic feedstock availability also affected producer costs, while tighter availability of selected chemical inputs encouraged manufacturers to maintain higher offers. Domestic pharmaceutical production provided a stable consumption base, while export requirements supported additional demand from overseas formulation markets.

During the second quarter of 2026, the ofloxacin prices in Germany reached 47,069 USD/MT in June. The market recorded an upward movement as pharmaceutical manufacturers faced continued cost pressure across chemical and energy intensive production activities. Demand from pharmaceutical formulation remained relatively stable, providing a firm consumption base for the API. Higher costs for upstream chemical materials also influenced production economics and encouraged suppliers to maintain firmer quotations.

During the second quarter of 2026, the ofloxacin prices in France reached 48,010 USD/MT in June. The market experienced upward price pressure as pharmaceutical manufacturers continued to manage elevated production and procurement costs. Demand from the healthcare sector remained supportive because ofloxacin continues to serve as an established antibacterial active ingredient in selected formulations. Higher upstream chemical expenses contributed to increased manufacturing costs, while international sourcing conditions influenced the availability and landed cost of pharmaceutical ingredients.

During the second quarter of 2026, the ofloxacin prices in Canada reached 43,890 USD/MT in June. Canadian prices increased as pharmaceutical buyers faced firmer international procurement costs and continued attention to API availability. The market remained influenced by overseas supply because pharmaceutical ingredients are traded through interconnected global manufacturing and distribution networks. Higher costs for chemical feedstocks increased the production economics of ofloxacin, while logistics and import related expenses added to delivered costs for downstream buyers.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing ofloxacin prices.

Europe Ofloxacin Price Trend

Q3 2026:

The ofloxacin price index in Europe moved upward through the quarter, supported by tighter prompt availability and firm downstream demand. Germany, a leading pharmaceutical processing market in the region, recorded steady offtake from tablet, injectable and ophthalmic formulation manufacturers despite the firmer pricing environment. France followed a similar pattern, with buyers maintaining regular procurement even as suppliers held firmer offers. European formulators depend substantially on imported active ingredient, so tighter availability and firmer replacement costs pushed quotations higher across the region. Distributors maintained lean inventories, which limited the volume of material available to non contract buyers seeking immediate delivery. Logistics constraints and periodic congestion at major ports restricted the timely movement of cargo and encouraged forward purchasing. Demand from hospital and retail pharmacy channels remained resilient despite the firmer cost base. Suppliers stayed cautious about discounting given the tighter prompt market, reinforcing the upward tone through the quarter.

Q2 2026:

The ofloxacin price index in Europe moved upward as pharmaceutical demand remained stable while production costs continued to influence supplier quotations. Germany and France both recorded higher prices, reflecting the combined effect of firm pharmaceutical consumption and elevated upstream manufacturing expenses. Energy and chemical input costs remained relevant because API production depends on several chemical processing stages and supporting utilities. European manufacturers and distributors also continued to monitor international pharmaceutical supply conditions, as dependence on globally integrated API networks can increase exposure to logistics disruptions and supplier availability. Procurement strategies remained focused on supply reliability, particularly for pharmaceutical manufacturers requiring consistent API availability.

This analysis can be extended to include detailed ofloxacin price information for a comprehensive list of countries.

North America Ofloxacin Price Trend

Q3 2026:

The ofloxacin price index in North America rose during the quarter, driven by tighter prompt availability and steady downstream demand. The USA, the leading consuming and processing market in the region, saw generic and branded formulators maintain active procurement of available active ingredient volumes. Canada followed a similar trend, with cross border buyers facing firmer replacement costs as strong domestic demand absorbed available material and reduced export flexibility. Regional formulators rely on a mix of domestic and imported active ingredient, so firmer international quotations and freight charges fed directly into landed costs. Distributors kept inventories conservative, reducing flexibility for buyers seeking prompt deliveries. Quality documentation and compliance requirements limited the number of qualified suppliers able to serve large contracts, which kept competition restrained. Demand for tablet and injectable formulations remained consistent across retail and institutional channels, supporting the firmer tone through the period. Forward purchasing increased as participants sought to secure cover ahead of expected firmer offers.

Q2 2026:

The ofloxacin price index in North America increased as supply constraints and higher manufacturing costs influenced the market. The United States recorded a stronger upward movement, while Canada also experienced firmer pricing. Availability of generic pharmaceutical ingredients remained an important consideration because manufacturing disruptions and quality related issues can reduce supply to formulation producers. The market was further influenced by higher costs for chemical feedstocks and energy intensive processing. Healthcare demand continued to provide a stable foundation for ofloxacin consumption, particularly across established pharmaceutical applications. Buyers remained focused on securing dependable API supplies, which supported procurement activity despite higher prices. International sourcing and logistics also affected regional costs because pharmaceutical supply chains remain dependent on cross border movement of active ingredients and intermediates.

Specific ofloxacin historical data within the United States and Canada can also be provided.

Middle East and Africa Ofloxacin Price Trend

Q3 2026:

The study includes ofloxacin price trends across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.

Q2 2026:

According to the ofloxacin price chart, prices in the Middle East and Africa exhibited fluctuations due to a combination of factors, mainly influenced by supply chain disruptions, changing seasonal demand patterns, and ongoing geopolitical developments.

In addition to region-wise data, information on ofloxacin prices for countries can also be provided.

Asia Pacific Ofloxacin Price Trend

Q3 2026:

The ofloxacin price index in Asia Pacific moved upward, supported by firm import replacement costs and steady pharmaceutical production demand. China, a principal producing and consuming market in the region, recorded firmer offers as active ingredient suppliers faced rising input and processing expenses. Regional formulators maintained steady procurement to meet ongoing therapy requirements across hospital and retail channels. Export competition among regional suppliers shaped the volumes available for cross border shipment. Firm freight and container availability at major ports influenced delivered costs for buyers across the region. Currency movements against supplying nations added to procurement costs for importers managing foreign denominated purchases. Suppliers maintained disciplined offers, which limited the volume of prompt material available to spot buyers. Quality and regulatory documentation requirements kept sourcing concentrated among established producers, reinforcing the firmer market tone.

Q2 2026:

The Asia Pacific ofloxacin market moved upward as manufacturing costs and pharmaceutical demand provided support. China remained an important production and supply center, benefiting from its established chemical and pharmaceutical manufacturing infrastructure. Higher costs for aromatic feedstocks and other upstream materials influenced the economics of API production and encouraged firmer supplier quotations. Domestic pharmaceutical manufacturing provided consistent consumption, while export demand added support from international buyers. Supply chain conditions remained significant because regional producers serve pharmaceutical markets across multiple countries. Buyers continued to monitor raw material availability and production schedules to manage procurement risks. India also remained important within the broader regional pharmaceutical supply network, although its dependence on Chinese starting materials for several APIs and pharmaceutical intermediates creates exposure to international supply conditions.

This ofloxacin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Ofloxacin Price Trend

Q3 2026:

The ofloxacin market in Latin America is primarily shaped by regional import dependency and downstream industrial demand across oral tablet formulations, injectable formulations, and ophthalmic and otic solution applications. However, due to logistics constraints and varying regulatory regimes, ofloxacin prices might fluctuate dynamically across the region.

Q2 2026:

The analysis of ofloxacin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Ofloxacin Pricing Report, Market Analysis, and News

IMARC's latest publication, “Ofloxacin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the ofloxacin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ofloxacin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ofloxacin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ofloxacin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Ofloxacin Industry Analysis

The global ofloxacin market size reached USD 1.20 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 1.69 Billion, at a projected CAGR of 3.89% during 2026-2034. Market growth is being driven by rising prevalence of bacterial infections requiring fluoroquinolone class antibacterial treatment, expanding use of ofloxacin in respiratory and urinary tract infection therapies, and growing generic drug manufacturing capacity supporting wider access to affordable antibacterial formulations across healthcare systems worldwide.

Latest News and Developments:

• December 2025: The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, issued a notice revising maximum retail prices for select cardiac, diabetes and antibiotic formulations sold in the country.
   
• September 2025: The NPPA fixed retail prices for 42 new drug formulations, including several antibiotic products, continuing its routine oversight of pharmaceutical pricing in the domestic market.
   
• September 2025: In a separate notification, the NPPA fixed retail prices for 42 formulations including amoxycillin, dapagliflozin and cefixime, as part of its continuing regulation of antibiotic and essential drug pricing.

Product Description

Ofloxacin is a synthetic broad spectrum antibacterial compound belonging to the fluoroquinolone class of antibiotics. It is chemically represented by the molecular formula C18H20FN3O4 and is typically supplied as a white to pale yellow crystalline powder. As a racemic compound, ofloxacin contains both enantiomers of its active structure, with one enantiomer accounting for the majority of its antibacterial activity. The compound exhibits its antibacterial action by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair. Commercial production follows a multi step organic synthesis route, beginning with a fluorinated aromatic precursor that undergoes cyclization to build the core quinolone ring system, followed by introduction of a piperazine side chain and subsequent purification, crystallization and drying steps to obtain the pharmaceutical grade active ingredient. The purified bulk material is tested against pharmacopoeial specifications before release to formulators. Ofloxacin's principal end use industry is pharmaceutical manufacturing, where it serves as the active pharmaceutical ingredient in oral tablets, injectable solutions, and ophthalmic and otic formulations. In oral and injectable forms, it is used in the treatment of respiratory tract infections, urinary tract infections, and certain skin and soft tissue infections. In ophthalmic and otic solutions, it functions as a topical antibacterial agent for eye and ear infections. The active ingredient is also incorporated into veterinary antibacterial products for animal health applications. Ofloxacin bulk drug substance is traded in powder form meeting recognized pharmacopoeial grades, while finished dose forms are marketed as tablets, sterile injectable solutions, and topical ophthalmic or otic drops.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of ofloxacin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting ofloxacin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ofloxacin price charts ensure our clients remain at the forefront of the industry.